Skip to main content
UFPTUFP Technologies, Inc.Hold5.6·$278.20+0.29%

UFP Technologies (UFPT) Q2 2026 earnings — TrendMatrix coverage

BEAT+14.2% vs estimateEPS $2.92 vs $2.56 estVerdict HoldSell

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$2.92
Estimate
$2.56
Surprise
+14.2%
Score at report (before → after)
5.15.1/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Report record · Q2 2026

How the report landed

UFP Technologies (UFPT) beat the $2.56 estimate with diluted EPS of $2.92 — a large 14.2% upside surprise. TrendMatrix's engine moved from Hold (5.1/10) to Sell at 5.1/10 after the report.

Current read · as of 2026-09-14

Where TrendMatrix's rating stands now

TrendMatrix currently rates UFPT Hold at 5.6/10.

4 of the last 4 quarters beat the estimate; this quarter's +14.2% surprise compares with a +10.2% four-quarter average. Next scheduled report: 2026-11-02.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Concentration risk — Customer: top ten customers (68.8%)
  • Thin upside margin: 8.6%
  • Negative momentum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$278.20
Price target
$301.75
Stop
$265.17
Upside to target
+8.5%
Reward-to-risk
1.5:1

The stock trades at 30.1× trailing but 23.4× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: RSI 9 — a level conventionally read as oversold.

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare context

UFPT at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Devices
Market cap
$2.15B
P/E (fwd)
23.4
P/E (ttm)
30.1
52-week range
$173.86$338.71
Off 52-week high
17.9%
RSI (14)
9
Volume vs avg
0.71×
Score today
5.6/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks UFPT Earnings Q2 2026 earnings